Globus Medical (MEX:GMED) Beta: 0.3781 (As of Jun. 28, 2026)


MEX:GMED Globus Medical Inc MEX:GMED
92 GF Score
Price MXN1,465.00
GF Value MXN1,675.11
Valuation Modestly Undervalued
! 5 Warning Signs
View Full Analysis

What is Globus Medical Beta?

Globus Medical MEX:GMED 92 Beta is 0.3781 as of Jun. 28, 2026. GuruFocus rates MEX:GMED with a GF Score™ of 92/100 and a GF Value™ of MXN1,675.11 (Modestly Undervalued). The stock has 5 warning signs investors should review.

Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. As of today (2026-06-28), Globus Medical's Beta is 0.3781.


Globus Medical  (MEX:GMED) Beta Explanation

Beta is a measure of the volatility, or systematic risk, of a security or a portfolio in comparison to the market as a whole. We usually compare beta to 1. A beta of 1 indicates that the security's price will move with the market. A beta of less than 1 means that the security will be less volatile than the market. A beta of greater than 1 indicates that the security's price will be more volatile than the market.

Beta is primarily used in the Capital Asset Pricing Model (CAPM) to calculate the Cost of Equity, which can be used in the calculation of WACC %. The formula of Cost of Equity is:
Cost of Equity = Risk-Free Rate of Return + Beta of Asset * (Expected Return of the Market - Risk-Free Rate of Return)


Globus Medical Beta Related Terms


Globus Medical Beta Historical Data

* Premium members only.

The historical data trend for Globus Medical's Beta can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Globus Medical Beta Chart

Globus Medical Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Beta
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 -0.17 -0.14 0.20

Globus Medical Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Beta Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.02 0.07 0.13 0.20 0.29

MEX:GMED vs PODD, PEN, MASI: Beta Comparison

For the Medical Devices subindustry, Globus Medical's Beta, along with its competitors' market caps and Beta data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Globus Medical Beta vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Globus Medical's Beta distribution charts can be found below:

* The bar in red indicates where Globus Medical's Beta falls into.


MEX:GMED
92GF Score
Globus Medical Inc MEX:GMED
Beta is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Globus Medical Beta Calculation

Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. A stock's beta can be calculated by dividing the product of the covariance of the individual stock's returns and the market's returns by the variance of the market's returns over a specified period. Basically, GuruFocus uses the returns calculated over three-year period.

Frequently Asked Questions Learn more about Beta →
What does a Beta of 0.3781 mean?
Globus Medical (MEX:GMED) has a Beta of 0.3781 as of Jun. 28, 2026. Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. View historical data for Globus Medical and its competitors.
Is Globus Medical's Beta too high?
Globus Medical's current Beta is 0.3781. Overall, Globus Medical has a GF Score™ of 92/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Globus Medical's Beta compare to PODD and PEN?
Globus Medical's Beta of 0.3781 can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Beta for a Medical Devices & Instruments company?
A good Beta depends on the Medical Devices & Instruments industry context. However, Beta should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Beta mean?
A high Beta can signal that a stock is expensive relative to its fundamentals. Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. View historical data for Globus Medical and its competitors. Globus Medical's current Beta is 0.3781. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Globus Medical stock overvalued right now?
Based on GuruFocus' analysis, Globus Medical (MEX:GMED) is currently considered Modestly Undervalued. The stock's GF Value™ is MXN1,675.11, compared to a current price of MXN1,465.00 — trading 12.5% below its estimated fair value. The current Beta is 0.3781. Globus Medical's overall GF Score™ is 92/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Beta calculated?
Beta is calculated from a company's financial statements. For Globus Medical (MEX:GMED), the current Beta is 0.3781 as of Jun. 28, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Globus Medical (MEX:GMED) Overvalued in 2026?

Based on GuruFocus' analysis, Globus Medical stock appears to be undervalued. The current stock price of MXN1,465.00 is trading 12.5% below its estimated GF Value™ of MXN1,675.11. GuruFocus considers Globus Medical to be Modestly Undervalued.

Key valuation signals for MEX:GMED:

  • Beta: 0.3781
  • GF Value™: MXN1,675.11 vs. price of MXN1,465.00 (12.5% below fair value)
  • GF Score™: 92/100 with 5 warning signs

No single metric tells the full story. See the MEX:GMED stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Globus Medical Business Description

Other Exchanges GMED:USAGM0N:Germany
Address 2560 General Armistead Avenue, Audubon, PA, USA, 19403
Globus Medical Inc is a medical device company that develops and provides healthcare products and solutions to hospitals, physicians, and surgical centers. The firm's products are organized into two categories: musculoskeletal solutions, which include medical devices and instruments used mostly for spinal and orthopedic procedures, and enabling technologies, which include computer systems developed for enhancing surgical capabilities. The vast majority of the company's revenue is generated from musculoskeletal solutions products, and more than half of the revenue is earned in the United States. It also has its presence internationally.
92GF Score

Get the complete analysis for MEX:GMED

Beta is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

MXN1,465.00
Price
MXN1,675.11
GF Value